These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 19183143)

  • 21. A case-control study of community-associated Clostridium difficile infection.
    Wilcox MH; Mooney L; Bendall R; Settle CD; Fawley WN
    J Antimicrob Chemother; 2008 Aug; 62(2):388-96. PubMed ID: 18434341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recurrent community-acquired pneumonia in patients starting acid-suppressing drugs.
    Eurich DT; Sadowski CA; Simpson SH; Marrie TJ; Majumdar SR
    Am J Med; 2010 Jan; 123(1):47-53. PubMed ID: 20102991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clostridium difficile infection in an urban medical center: five-year analysis of infection rates among adult admissions and association with the use of proton pump inhibitors.
    Jayatilaka S; Shakov R; Eddi R; Bakaj G; Baddoura WJ; DeBari VA
    Ann Clin Lab Sci; 2007; 37(3):241-7. PubMed ID: 17709687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection.
    Stevens V; Dumyati G; Fine LS; Fisher SG; van Wijngaarden E
    Clin Infect Dis; 2011 Jul; 53(1):42-8. PubMed ID: 21653301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proton pump inhibitors and diarrhoea related to Clostridium difficile infection in hospitalised patients: a case-control study.
    Leonard AD; Ho KM; Flexman J
    Intern Med J; 2012 May; 42(5):591-4. PubMed ID: 22616966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overuse and inappropriate prescribing of proton pump inhibitors in patients with Clostridium difficile-associated disease.
    Choudhry MN; Soran H; Ziglam HM
    QJM; 2008 Jun; 101(6):445-8. PubMed ID: 18411220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proton pump inhibitors as a risk factor for paediatric Clostridium difficile infection.
    Turco R; Martinelli M; Miele E; Roscetto E; Del Pezzo M; Greco L; Staiano A
    Aliment Pharmacol Ther; 2010 Apr; 31(7):754-9. PubMed ID: 20047577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of Clostridium difficile infection in hospitalized patients receiving metronidazole for a non-C difficile infection.
    Rodriguez S; Hernandez MB; Tarchini G; Zaleski M; Vatanchi M; Cardona L; Castro-Pavia F; Schneider A
    Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1856-61. PubMed ID: 24681079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Type-specific risk factors and outcome in an outbreak with 2 different Clostridium difficile types simultaneously in 1 hospital.
    Goorhuis A; Debast SB; Dutilh JC; van Kinschot CM; Harmanus C; Cannegieter SC; Hagen EC; Kuijper EJ
    Clin Infect Dis; 2011 Nov; 53(9):860-9. PubMed ID: 21914851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of proton pump inhibitor use on risk of Clostridium difficile infection: a hospital cohort study.
    Park YH; Seong JM; Cho S; Han HW; Kim JY; An SH; Gwak HS
    J Gastroenterol; 2019 Dec; 54(12):1052-1060. PubMed ID: 31187275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Community-associated Clostridium difficile infection among older people in Tayside, Scotland, is associated with antibiotic exposure and care home residence: cohort study with nested case-control.
    Marwick CA; Yu N; Lockhart MC; McGuigan CC; Wiuff C; Davey PG; Donnan PT
    J Antimicrob Chemother; 2013 Dec; 68(12):2927-33. PubMed ID: 23825381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Health care-associated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: a Canadian Nosocomial Infection Surveillance Program Study.
    Gravel D; Miller M; Simor A; Taylor G; Gardam M; McGeer A; Hutchinson J; Moore D; Kelly S; Boyd D; Mulvey M;
    Clin Infect Dis; 2009 Mar; 48(5):568-76. PubMed ID: 19191641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence and risk factors for hospital-acquired Clostridium difficile infection among inpatients in an orthopaedic tertiary care hospital.
    Campbell KA; Phillips MS; Stachel A; Bosco JA; Mehta SA
    J Hosp Infect; 2013 Feb; 83(2):146-9. PubMed ID: 23313026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proton Pump Inhibitors Do Not Increase Risk for Clostridium difficile Infection in the Intensive Care Unit.
    Faleck DM; Salmasian H; Furuya EY; Larson EL; Abrams JA; Freedberg DE
    Am J Gastroenterol; 2016 Nov; 111(11):1641-1648. PubMed ID: 27575714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multimorbidity in elderly hospitalised patients and risk of Clostridium difficile infection: a retrospective study with the Cumulative Illness Rating Scale (CIRS).
    Ticinesi A; Nouvenne A; Folesani G; Prati B; Morelli I; Guida L; Turroni F; Ventura M; Lauretani F; Maggio M; Meschi T
    BMJ Open; 2015 Oct; 5(10):e009316. PubMed ID: 26503394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality.
    Miller M; Gravel D; Mulvey M; Taylor G; Boyd D; Simor A; Gardam M; McGeer A; Hutchinson J; Moore D; Kelly S
    Clin Infect Dis; 2010 Jan; 50(2):194-201. PubMed ID: 20025526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clostridium difficile--associated disease in a setting of endemicity: identification of novel risk factors.
    Dubberke ER; Reske KA; Yan Y; Olsen MA; McDonald LC; Fraser VJ
    Clin Infect Dis; 2007 Dec; 45(12):1543-9. PubMed ID: 18190314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implementation of Global Strategies to Prevent Hospital-Onset Clostridium difficile Infection: Targeting Proton Pump Inhibitors and Probiotics.
    Lewis PO; Lundberg TS; Tharp JL; Runnels CW
    Ann Pharmacother; 2017 Oct; 51(10):848-854. PubMed ID: 28821215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of a pharmacist-driven protocol to decrease proton pump inhibitor use in non-intensive care hospitalized adults.
    Michal J; Henry T; Street C
    Am J Health Syst Pharm; 2016 Sep; 73(17 Suppl 4):S126-32. PubMed ID: 27543598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of an outbreak of Clostridium difficile infection controlled with enhanced infection control measures.
    Salgado CD; Mauldin PD; Fogle PJ; Bosso JA
    Am J Infect Control; 2009 Aug; 37(6):458-64. PubMed ID: 19243859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.